Stock Price & Analysis

Sell WAY stock as insider selling activity and bearish options sentiment indicate negative outlook.

The price prediction for WAY stock in 2025 is expected to reach $40.38, driven by its Fibonacci pivot level and potential rebound from oversold conditions. If the stock breaks above resistance, it could target $44.21, but if it fails to hold support, it may drop to $34.18.

The S1 support level for WAY Stock is $35.74 ,The R1 resistant level for WAY Stock is $43.4.

As of the end of day on 2025-03-14, the price of WAY Stock was $36.44.

The target price for WAY Stock according to analyst rating is 49.86, with the highest price target at 51.00 and the lowest at 47.00. Analysts have a Strong Buy rating on WAY Stock overall.

The market cap of WAY is $6.3B.

Analysis and Insights

WAY (Waystar Holding Corp) appears to be overvalued based on its current valuation metrics and market sentiment.

Valuation Metrics:

WAY's valuation metrics suggest a premium relative to its peers. The stock currently trades at a price-to-sales (PS) ratio of 2.05 and a price-to-book (PB) ratio of 2.05, indicating a significant premium to its book value and revenue. Additionally, its enterprise value-to-EBITDA (EV/EBITDA) ratio of 6.31 reflects a higher valuation compared to industry averages.

Analyst Sentiment:

Despite the premium valuation, analysts remain bullish on WAY, with multiple price target increases in recent months. For example, Canaccord Genuity raised its price target to $50 from $42, citing strong revenue growth and improved margins. Barclays also raised its target to $50, highlighting the company's ability to exceed estimates.

{RATING:symbol=WAY.O, type=0}

Insider Activity:

Insider selling has been significant, with the Chief Transformation Officer selling 26% of his holdings and a director selling 20.2% of his shares. This could indicate a lack of confidence in the stock's short-term prospects.

Options Activity:

The high volume of put options, particularly for the $37.50 strike expiring in March 2025, suggests bearish sentiment among option traders. This could indicate expectations of a potential price decline.

Conclusion:

WAY's high valuation multiples, combined with significant insider selling and bearish options activity, suggest the stock may be overvalued. While analysts remain optimistic, investors should exercise caution and consider waiting for a pullback or more favorable entry point.

Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. The Company’s enterprise-grade platform, Waystar, streamlines the complex processes. It leverages internally developed artificial intelligence (AI) as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, enriches data integrity, and reduces labor costs for providers. The Company’s software is used daily by providers of all types and sizes across the continuum of care, including physician practices, clinics, surgical centers, and laboratories, as well as large hospitals and health systems. Its clients utilize its software to manage pre-encounter workflows, such as eligibility checks and prior authorization approvals, as well as mid- and post-encounter workflows, such as co-pay collection, claims submission and monitoring, and payer remittances.

The price prediction for WAY stock by 2030 is expected to reach $60-$80 per share, driven by strong revenue growth, high customer retention, and positive analyst sentiment. Analysts have raised their price targets, citing the company's ability to outperform estimates and expand its market share.

WAY has a total of 1400 employees.